Skip to content
1 min left
0% read
Exabeam logo

Exabeam

Investment Firm
Singapore
Founded 2003
850

Exabeam delivers threat research and out-of-the-box content so that you can quickly defend against emerging cyberthreats

Share:

Exabeam Overview

Exabeam is a global cybersecurity leader that delivers AI-driven security operations. High-integrity data ingestion, powerful analytics, and workflow automation power the industry's most advanced self-managed and cloud-native security operations platform for threat detection, investigation, and response (TDIR).

With a history of leadership in SIEM and UEBA, and a legacy rooted in AI, Exabeam empowers global security teams to combat cyberthreats, mitigate risk, and streamline security operations. Learn more at www.exabeam.com.

Frequently Asked Questions About Exabeam

Exabeam is a finance company. Exabeam delivers threat research and out-of-the-box content so that you can quickly defend against emerging cyberthreats

Exabeam is a global cybersecurity leader that delivers AI-driven security operations. High-integrity data ingestion, powerful analytics, and workflow automation power the industry's most advanced self-managed and cloud-native security operations platform for threat detection, investigation, and resp.

Exabeam has been operating since 2003. You can verify their legitimacy through their official website and social media presence.

Exabeam operates in the finance sector of the cryptocurrency industry. Compare Exabeam with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Exabeam, research their track record (operating since 2003), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Exabeam is based in Singapore, has been operating since 2003. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Exabeam is based in Singapore, North America, with offices in Singapore, Foster City, California, USA, Maidenhead, England.

Exabeam was founded in 2003. The company currently has 850 employees.

Exabeam Details

Exabeam Offices (21)

Exabeam Tags

More About Exabeam

Work Model Details
Employees engage in a combination of remote and on-site work.

Latest from Academy

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

7m
 Why Tokenlon's Revenue Doesn't Match Its Token Price

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia Halland logoMia HallandApr 26, 2026
8m
Sixty-Five Million in BioDAOs, BIO at One Cent

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

8m